| Literature DB >> 34915852 |
Christian Thilo1, Christine Meisinger2,3, Margit Heier4,5, Wolfgang von Scheidt6, Inge Kirchberger7,8,9.
Abstract
BACKGROUND: The association between the presence of a diagonal earlobe crease (DEC) and coronary artery disease has been prescribed earlier. However, it is unclear whether patients with acute myocardial infarction (AMI) and DEC have a higher risk of dying.Entities:
Keywords: Diagonal earlobe crease; Frank’s sign; Myocardial infarction; Survival
Mesh:
Year: 2021 PMID: 34915852 PMCID: PMC8679982 DOI: 10.1186/s12872-021-02425-4
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1Examples of ear lobe crease classification
Fig. 2Flow diagram
Demographic and clinical characteristics of the study population with and without diagonal earlobe crease (n = 655)
| Total | DEC grade 0/1 | DEC grade 2/3 | |||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||
| Age | 67.95 | 10.78 | 62.43 | 11.60 | 70.60 | 9.26 | < 0.0001 |
| C-reactive protein | 1.85 | 8.88 | 1.81 | 4.46 | 1.87 | 5.27 | 0.0287 |
DEC diagonal ear lobe crease, HISIHD history of ischemic heart disease, COPD chronic obstructive pulmonary disease, PAOD peripheral arterial occlusive disease, STEMI ST-elevation myocardial infarction, NSTEMI non ST-elevation myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, LVEF left ventricular ejection fraction
*Shock, stroke, bleading, brady/tachycardia, atrial fibrillation, lung edema
Frequency of different diagonal ear lobe crease severity grades (n = 655)
| Severity grade | n | % | |
|---|---|---|---|
| Right ear (n = 642) | 0 | 102 | 15.89 |
| 1 | 172 | 26.79 | |
| 2 | 254 | 39.56 | |
| 3 | 114 | 17.76 | |
| Left ear (n = 640) | 0 | 101 | 15.78 |
| 1 | 169 | 26.41 | |
| 2 | 261 | 40.78 | |
| 3 | 109 | 17.03 | |
| Ear with strongest severity | 0 | 68 | 10.38 |
| 1 | 145 | 22.14 | |
| 2 | 292 | 44.58 | |
| 3 | 150 | 22.90 | |
| Aggregate of both ears (n = 627) | 0 | 62 | 9.89 |
| 1 | 49 | 7.81 | |
| 2 | 105 | 16.75 | |
| 3 | 105 | 16.75 | |
| 4 | 170 | 27.11 | |
| 5 | 63 | 10.05 | |
| 6 | 73 | 11.64 | |
| Grade 2 or 3 on ≥ 1 ear | |||
| No | 213 | 32.52 | |
| Yes | 442 | 67.48 | |
| Grade 3 on ≥ 1 ear | |||
| No | 505 | 77.10 | |
| Yes | 150 | 22.90 |
Fig. 3Three-year survival of 655 patients with myocardial infarction according to diagonal ear lobe crease grading
Cox proportional hazards models: associations with all cause 1-year and 3-year mortality in patients with acute myocardial infarction (n = 651)
| Variable | Reference | 1-year mortality | 3-year mortality | ||||
|---|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | Hazard ratio | 95% CI | ||||
| DEC (grade 2/3) | Grade 0/1 | 2.57 | 1.07–6.17 | 0.0347 | 1.48 | 0.94–2.34 | 0.0897 |
| Gender (female) | Male | 0.60 | 0.31–1.16 | 0.1301 | 0.71 | 0.47–1.08 | 0.1046 |
| Age [years] | 1.05 | 1.01–1.09 | 0.0242 | 1.03 | 1.01–1.06 | 0.0057 | |
| Diabetes mellitus (yes) | No | 1.02 | 0.54–1.91 | 0.9632 | 1.05 | 0.70–1.56 | 0.8177 |
| PAOD (yes) | No | 1.90 | 0.98–3.67 | 0.0566 | 2.11 | 1.37–3.25 | 0.0007 |
| History of stroke (yes) | No | 1.56 | 0.75–3.23 | 0.2334 | 1.55 | 0.96–2.49 | 0.0717 |
| Chronic kidney disease (yes) | No | 1.19 | 0.57–2.46 | 0.6423 | 1.39 | 0.88–2.22 | 0.1628 |
| Reinfarction (yes) | No | 1.39 | 0.69 –2.83 | 0.3595 | 0.83 | 0.55–1.25 | 0.3784 |
| Any recanalization therapy (yes) | No | 0.34 | 0.15–0.76 | 0.0088 | 0.63 | 0.37–1.10 | 0.1046 |
| LVEF < 50 | ≥ 50 | 2.27 | 1.16–4.42 | 0.0161 | 2.21 | 1.47–3.32 | 0.0002 |
| 1-VD | 3-VD | 0.64 | 0.25–1.65 | 0.3531 | 0.74 | 0.42–1.31 | 0.2965 |
| 2-VD | 3-VD | 1.28 | 0.64–2.58 | 0.4839 | 1.21 | 0.77–1.91 | 0.4107 |
| VD: Others, missing | 3-VD | 1.12 | 0.38–3.23 | 0.8415 | 1.39 | 0.67–2.87 | 0.3735 |
| CRP > 3 mg/dl | ≤ 3 mg/l | 4.02 | 2.18–7.41 | < 0.0001 | 3.13 | 2.09–4.68 | < 0.0001 |
| CRP data missing | ≤ 3 mg/l | 1.29 | 0.38–4.40 | 0.6861 | 0.94 | 0.42–2.08 | 0.8768 |
CI confidence interval, DEC diagonal ear lobe crease, PAOD peripheral arterial occlusive disease, LVEF left ventricular ejection fraction, VD vessel disease, CRP c-reactive protein